COMM_BRFS: revenue barely grew, and one-offs propped up profit
Contents

On 25 November COMM_BRFS reported results for the third quarter of 2026. Revenue was USD 3,074.8m, up just 0.9% year on year after 14.1% in the second quarter, EBITDA fell 0.5% to USD 463.9m, and net profit rose 2.4% to USD 150.4m. At EV/EBITDA 3.07 and P/E 5.81 the stock trades below its own history, but revenue decelerating to 0.9% and falling EBITDA leave no case for calling it attractive. Our conclusion: fairly valued, because the discount to history is not backed by growth. Our view: the share is fairly valued.
Our view: is there upside
Our view in numbers
| Metric | Our read |
|---|---|
| Verdict | Neutral |
| Upside on the portal model | no portal model for this share |
| Net debt / EBITDA | 1.73 – moderate leverage |
| Strongest case for | EV/EBITDA 3.07 and P/E 5.81 with ROE of 20.6% and debt at 1.73x EBITDA make the stock cheap if earnings are sustainable. |
| Strongest case against | Revenue grew just 0.9%, EBITDA fell 0.5%, and free cash flow compressed to 51m – growth has stalled. |
| What would change the view | A return of revenue to double-digit growth (above 10% year on year) would move the verdict one step up; a decline in revenue would move it one step down. |
Key takeaways
— Revenue added just 0.9% year on year after 14.1% a quarter earlier – growth has almost stalled
— EBITDA fell 0.5% to 463.9m, and the 15.1% margin came in below last year's 15.3%
— Net profit rose 2.4% to 150.4m even as operating profit slipped to 280.7m
— Operating cash flow dropped to 261.4m against capex of 210.0m – free cash flow compressed
— Net debt of 3,037.0m at 1.73x LTM EBITDA is moderate, but the facts give no direction for the ratio
— EV/EBITDA 3.07 and P/E 5.81 put the stock below its own history, but the discount is not backed by growth
Key figures, USD bn
| Metric | Q3 2025 | Q3 2026 | Change |
|---|---|---|---|
| Revenue | 3.05 | 3.07 | +0.9% |
| EBITDA | 0.47 | 0.46 | -0.5% |
| Operating profit | 0.30 | 0.28 | -6.7% |
| Net profit | 0.15 | 0.15 | +2.4% |
| Operating cash flow | 0.44 | 0.26 | -40.1% |
| Capex | 0.19 | 0.21 | +9.7% |
| EBITDA margin | 15.3% | 15.1% | -0.2 pp |
| Net margin | 4.8% | 4.9% | +0.1 pp |
Revenue added just 0.9% year on year after 14.1% a quarter earlier – growth has almost stalled
In the third quarter of 2026 revenue was USD 3,074.8m, up 0.9% on a year earlier. That is a marked deceleration from the second quarter, when growth reached 14.1%. The quarterly sequence shows that after the spike in the fourth quarter of 2025 (65.1%) the pace fell steadily: 10.7% in the first quarter of 2026, 14.1% in the second and 0.9% in the third.
The trailing-twelve-month figure of USD 12,500.0m exceeds any single quarter's annualised run rate, but it is the quarterly dynamic that shows growth has practically stalled. The facts do not disclose the cause of the slowdown, and we do not venture to name one.
For a holder this is the main signal in the report: the company has stopped growing revenue at a pace that would justify growth expectations. If the figure does not return to double-digit rates next quarter, the discount to history will remain justified.
Revenue and EBITDA by quarter
| Period | Measure | bn USD |
|---|---|---|
| Q4 2024 | Revenue | 1.9664000000000001 |
| Q1 2025 | Revenue | 2.760146 |
| Q2 2025 | Revenue | 2.75579 |
| Q3 2025 | Revenue | 3.0466729999999997 |
| Q4 2025 | Revenue | 3.245843 |
| Q1 2026 | Revenue | 3.054646 |
| Q2 2026 | Revenue | 3.144354 |
| Q3 2026 | Revenue | 3.074768 |
| Q4 2024 | EBITDA | 0.456836 |
| Q1 2025 | EBITDA | 0.484493 |
| Q2 2025 | EBITDA | 0.44190300000000005 |
| Q3 2025 | EBITDA | 0.466171 |
| Q4 2025 | EBITDA | 0.459066 |
| Q1 2026 | EBITDA | 0.466129 |
| Q2 2026 | EBITDA | 0.487517 |
| Q3 2026 | EBITDA | 0.463913 |
EBITDA margin
| Period | Measure | % |
|---|---|---|
| Q4 2024 | EBITDA margin | 23.2 |
| Q1 2025 | EBITDA margin | 17.6 |
| Q2 2025 | EBITDA margin | 16.0 |
| Q3 2025 | EBITDA margin | 15.3 |
| Q4 2025 | EBITDA margin | 14.1 |
| Q1 2026 | EBITDA margin | 15.3 |
| Q2 2026 | EBITDA margin | 15.5 |
| Q3 2026 | EBITDA margin | 15.1 |
EBITDA fell 0.5% to 463.9m, and the 15.1% margin came in below last year's 15.3%
EBITDA for the third quarter of 2026 was USD 463.9m, down 0.5% on a year earlier. The EBITDA margin slipped to 15.1% from 15.3% a year earlier. With revenue almost flat, the company could not hold the absolute EBITDA level.
Operating profit fell to USD 280.7m, a deeper decline than EBITDA: pressure came not only at the operating-expense line but below it as well. Net profit nevertheless rose – the gap between operating and net profit points to items below the operating line that the facts do not detail.
A 15.1% margin is not a catastrophe, but it is below last year's while revenue barely grew. The company is operating in conditions where each percentage point of revenue is harder to win, and profitability is not improving.
Net profit by quarter
| Period | Measure | bn USD |
|---|---|---|
| Q4 2024 | Net profit | 0.140457 |
| Q1 2025 | Net profit | 0.210867 |
| Q2 2025 | Net profit | 0.131815 |
| Q3 2025 | Net profit | 0.146797 |
| Q4 2025 | Net profit | 0.105572 |
| Q1 2026 | Net profit | 0.107391 |
| Q2 2026 | Net profit | 0.107315 |
| Q3 2026 | Net profit | 0.15035900000000002 |
Net profit rose 2.4% to 150.4m even as operating profit slipped to 280.7m
Net profit for the third quarter of 2026 was USD 150.4m, up 2.4% on a year earlier. The net margin rose to 4.9% from 4.8%. Profit growth alongside a fall in operating profit to 280.7m means the result was supported by items below the operating line.
Over the trailing twelve months net profit was USD 470.6m on revenue of 12,500.0m and EBITDA of 1,752.1m. That is a stable level, but the quarterly dynamic shows profit growing more slowly than one would want at this valuation.
The gap between operating and net profit is the key question for the quality of the result. If profit was supported by one-off items, the sustainable level may be below the reported figure.
Operating cash flow dropped to 261.4m against capex of 210.0m – free cash flow compressed
Operating cash flow for the third quarter of 2026 was USD 261.4m, and capital expenditure was USD 210.0m. The difference – about 51m – is the quarter's free cash flow, and it is small relative to EBITDA of 463.9m.
Over the trailing twelve months operating cash flow was USD 1,530.6m, well above the quarterly level, but the quarterly figure shows compression. With capex of 210.0m the company spends almost half of its operating cash flow on investment.
Free cash flow of 51m against net profit of 150.4m means profit is not fully converting into cash. For a holder this matters more than reported profit: it is cash flow that funds debt and dividends.
Net debt of 3,037.0m at 1.73x LTM EBITDA is moderate, but the facts give no direction for the ratio
Net debt at 30 September 2026 was USD 3,037.0m, or 1.73x trailing-twelve-month EBITDA of 1,752.1m. That is a moderate level: the company services its debt without strain, but the cushion is not unlimited.
The facts do not contain a prior value for the net debt / EBITDA ratio, so we do not claim leverage rose or fell. Absolute debt of 3,037.0m against a market capitalisation of 2,732.4m means debt is comparable to equity – that is material for valuation.
With quarterly operating cash flow of 261.4m, debt service does not look like a problem, but free cash flow compressing to 51m leaves less room for manoeuvre if revenue keeps stagnating.
EV/EBITDA 3.07 and P/E 5.81 put the stock below its own history, but the discount is not backed by growth
EV/EBITDA on a trailing-twelve-month basis is 3.07, and P/E is 5.81. Both multiples are low in absolute terms, reflecting moderate leverage as well as a modest market valuation of earnings. Return on equity is 20.6% – the company earns on capital better than the multiples would suggest.
The facts do not allow a comparison of the current multiple with the company's own three-year history: no three-year average is given. But the combination of EV/EBITDA 3.07, P/E 5.81 and ROE 20.6% says the market is not pricing in growth – it is pricing in stagnation.
A discount to history would be a cushion if revenue were growing. With growth at 0.9% and EBITDA down 0.5%, the discount reflects the fundamental picture rather than undervaluation. That is why we do not call the stock attractive.
Valuation on the latest reported figures
| Metric | Value |
|---|---|
| Market cap | 2.73 bn USD |
| P/E (LTM) | 5.8 |
| EV/EBITDA (LTM) | 3.1 |
| P/B | 1.00 |
| Net debt / EBITDA (LTM) | 1.73 |
| Operating cash flow (LTM) | 1.53 bn |
| ROE | 20.6% |
Bottom line
The report's strengths remain moderate leverage (1.73x EBITDA) and ROE of 20.6% at low multiples of EV/EBITDA 3.07 and P/E 5.81. But revenue grew just 0.9%, EBITDA fell 0.5%, and free cash flow compressed to 51m – growth has practically stalled. Net profit of 150.4m rose while operating profit fell to 280.7m, and the quality of that growth is questionable. Our conclusion: fairly valued – the discount to history is not backed by growth, and a return of revenue to double-digit rates is needed to change the verdict. Our view: the share is fairly valued.